These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18269596)

  • 21. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
    Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
    Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allergic contact dermatitis to propyl gallate and pentylene glycol in an emollient cream.
    Foti C; Bonamonte D; Cassano N; Conserva A; Vena GA
    Australas J Dermatol; 2010 May; 51(2):147-8. PubMed ID: 20546226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical nicotinamide for seborrheic dermatitis: an open randomized study.
    Fabbrocini G; Cantelli M; Monfrecola G
    J Dermatolog Treat; 2014 Jun; 25(3):241-5. PubMed ID: 23763270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrhoeic dermatitis.
    Dupuy P; Maurette C; Amoric JC; Chosidow O;
    Br J Dermatol; 2001 May; 144(5):1033-7. PubMed ID: 11359393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.
    Elewski BE; Abramovits W; Kempers S; Schlessinger J; Rosen T; Gupta AK; Abraham S; Rowell R
    J Drugs Dermatol; 2007 Oct; 6(10):1001-8. PubMed ID: 17966177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An open-label study of the safety and efficacy of sertaconazole nitrate in the treatment of seborrheic dermatitis.
    Elewski BE; Cantrell WC
    J Drugs Dermatol; 2011 Aug; 10(8):895-9. PubMed ID: 21818511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of a cream containing AR-GG27® (sorbityl furfural palmitate) in the treatment of mild/moderate childhood atopic dermatitis associated with pityriasis alba. A double-blind, placebo-controlled clinical trial.
    Patrizi A; Raone B; Raboni R; Neri I
    G Ital Dermatol Venereol; 2012 Dec; 147(6 Suppl 1):1-8. PubMed ID: 23007324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV.
    de Moraes AP; de Arruda EA; Vitoriano MA; de Moraes Filho MO; Bezerra FA; de Magalhães Holanda E; de Moraes ME
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):596-601. PubMed ID: 17447972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study.
    Ozden MG; Tekin NS; Ilter N; Ankarali H
    Am J Clin Dermatol; 2010; 11(1):51-4. PubMed ID: 20000875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo.
    Shuster S; Meynadier J; Kerl H; Nolting S
    Arch Dermatol; 2005 Jan; 141(1):47-52. PubMed ID: 15655141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adults.
    Abramovits W; Hebert AA; Boguniewicz M; Kempers SE; Tschen E; Jarratt MT; Lucky AW; Cornelison RL; Swinyer LJ; Jones TM
    J Dermatolog Treat; 2008; 19(6):327-32. PubMed ID: 18728923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial.
    Lebwohl M; Plott T
    Int J Dermatol; 2004 Jul; 43 Suppl 1():17-20. PubMed ID: 15271196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial.
    Menter A; Gold LS; Bukhalo M; Grekin S; Kempers S; Boyce BM; Ganslandt C; Villumsen J; Lebwohl M
    J Drugs Dermatol; 2013 Jan; 12(1):92-8. PubMed ID: 23377334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of topical 4% Quassia amara gel in facial seborrheic dermatitis:a randomized, double-blind, comparative study.
    Diehl C; Ferrari A
    J Drugs Dermatol; 2013 Mar; 12(3):312-5. PubMed ID: 23545914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study.
    Gribetz C; Ling M; Lebwohl M; Pariser D; Draelos Z; Gottlieb AB; Zaias N; Chen DM; Parneix-Spake A; Hultsch T; Menter A
    J Am Acad Dermatol; 2004 Nov; 51(5):731-8. PubMed ID: 15523351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium gluconate in the treatment of seborrhoeic dermatitis: a multicenter, randomised, double-blind study versus placebo.
    Dreno B; Moyse D
    Eur J Dermatol; 2002; 12(6):549-52. PubMed ID: 12459525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
    Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
    Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.